Transcutaneous delivery of disease-specific PI3K/Akt/mTOR inhibitor-based hybrid nanoparticles in hydrogel system for the management of psoriasis: Insights from in vivo studies
Roshan Keshari, Rupali Bagale, Sulagna Rath, Abhijit De, Rinti Banerjee, Shamik Sen, Rohit Srivastava
Topics & Concepts
PI3K/AKT/mTOR pathwayIn vivoPsoriasisMedicineDiscovery and development of mTOR inhibitorsDrug deliveryProtein kinase BDelivery systemNanoparticlePharmacologyChemistryNanotechnologyMaterials scienceImmunologySignal transductionBiologyBiochemistryBiotechnologyPsoriasis: Treatment and PathogenesisClick Chemistry and ApplicationsRetinoids in leukemia and cellular processes